OCT 14, 2019 2:21 PM PDT

Injectable Drug reverses symptoms of liver disease in people with HIV

WRITTEN BY: Nouran Amin

In a study conducted by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Cancer Institute, scientists report that an injectable hormone ‘tesamorelin’ works to reduce liver fat and prevent liver fibrosis (scarring) in HIV patients with non-alcoholic fatty liver disease, or NAFLD.

National Institute of Allergy and Infectious Disease: A microscopic image of liver tissue affected by non-alcoholic fatty liver disease (NAFLD). The large and small white spots are excess fat droplets filling liver cells (hepatocytes). Credit: Dr. David Kleiner, NCI

"Many people living with HIV have overcome significant obstacles to live longer, healthier lives, though many still experience liver disease," said NIAID Director Anthony S. Fauci, M.D. "It is encouraging that tesamorelin, a drug already approved to treat other complications of HIV, may be effective in addressing non-alcoholic fatty liver disease."

Learn more about non-alcoholic fatty liver disease, or NAFLD:

 

 

"Our hope is that this intervention may help people living with HIV, as well as benefit HIV-negative people with liver abnormalities," said Dr. Hadigan. "Further research may inform us of the potential long-term benefits of this approach and develop formulations that can benefit everyone with liver disease, regardless of HIV status."

Tesamorelin, also known as Egrifta, was approved by the U.S. Food and Drug Administration in 2010 and works to reduce excess fat around the abdomen. Findings were published in The Lancet HIV.

"Because tesamorelin proved effective in treating abnormal fat build-up in the abdomens of people in the context of HIV and related medication use, we hypothesized that the drug might also reduce fat that accrues in the liver and causes damage in a similar population," said Steven K. Grinspoon, M.D., Chief of the Metabolism Unit at MGH.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 12, 2019
Drug Discovery & Development
DEC 12, 2019
Probiotics Treat Alcohol-Induced Liver Injury
Alcoholic liver injury is caused by overconsumption of alcohol, something that can lead to serious diseases such as liver steatosis, liver cirrhosis and li...
DEC 20, 2019
Drug Discovery & Development
DEC 20, 2019
Drug Repurposing May Provide Hope for Deadly Childhood Seizure Disorder
The life-threatening and treatment-resistant seizure disorder among children known as the ‘Dravet Syndrome’ may soon have new safe and effectiv...
DEC 21, 2019
Drug Discovery & Development
DEC 21, 2019
Improving Vaccines for Meningitis
Scientists at the University of Nottingham are seeking new ways to improve vaccine use in the protection against the bacterium, Neisseria meningitides that...
DEC 25, 2019
Drug Discovery & Development
DEC 25, 2019
New Drug to Make Breast Cancer Treatment More Affordable
The US Food and Drug Administration has granted accelerated approval to new breast cancer drug, trastuzumab deruxtecan. The drug’s increasing recogni...
FEB 06, 2020
Drug Discovery & Development
FEB 06, 2020
China Begins Trials for Antiviral Drug to Tackle Coronavirus
So far, coronavirus has infected over 31,493 people globally, and has killed 638. Although 1,563 people have reportedly recovered, due to its fast-spreadin...
FEB 28, 2020
Drug Discovery & Development
FEB 28, 2020
How Dietary Supplement Citicoline Improves Memory
For some time now, Citicoline has been known for its ability to improve memory and reduce cognitive decline. A primary ingredient in many pre-made nootropi...
Loading Comments...